A Study of T3011 Administered Via Intratumoral Injection in Patients With Advanced Solid Tumors
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumor|Sarcoma|HNSCC|Breast Cancer|Esophagus Cancer|NSCLC|Non-melanoma Skin Cancer
Interventions: BIOLOGICAL: T3011|BIOLOGICAL: T3011|BIOLOGICAL: T3011|BIOLOGICAL: T3011|BIOLOGICAL: T3011|BIOLOGICAL: T3011|BIOLOGICAL: T3011
Sponsor: ImmVira Pharma Co. Ltd